These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16626808

  • 21. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI, Cavada C, de Sagarra MR, Cuadrado A.
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [Abstract] [Full Text] [Related]

  • 22. Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.
    Jackson MJ, Smith LA, Al-Barghouthy G, Rose S, Jenner P.
    Exp Neurol; 2007 Mar; 204(1):162-70. PubMed ID: 17113078
    [Abstract] [Full Text] [Related]

  • 23. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP, Vassout A, Waldmeier P, Gentsch C.
    Eur J Pharmacol; 1998 Jul 17; 353(1):1-4. PubMed ID: 9721033
    [Abstract] [Full Text] [Related]

  • 24. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
    Chalimoniuk M, Langfort J.
    Neurochem Int; 2007 May 17; 50(6):821-33. PubMed ID: 17379358
    [Abstract] [Full Text] [Related]

  • 25. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 26. Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys.
    Doan VD, Grondin R, Hadj Tahar A, Grégoire L, Bédard PJ.
    Clin Neuropharmacol; 1999 Dec 26; 22(5):281-7. PubMed ID: 10516879
    [Abstract] [Full Text] [Related]

  • 27. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 28. LABORAS: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour.
    Quinn LP, Stean TO, Trail B, Duxon MS, Stratton SC, Billinton A, Upton N.
    J Neurosci Methods; 2003 Nov 30; 130(1):83-92. PubMed ID: 14583407
    [Abstract] [Full Text] [Related]

  • 29. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.
    Eur J Pharmacol; 2009 Sep 01; 617(1-3):33-40. PubMed ID: 19545563
    [Abstract] [Full Text] [Related]

  • 30. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J, Mørk A, Brennum LT, Sager TN.
    Neuroreport; 2009 Mar 25; 20(5):482-6. PubMed ID: 19262413
    [Abstract] [Full Text] [Related]

  • 31. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C, Saint-Pierre M, Bousquet M, Lévesque D, Rouillard C, Cicchetti F.
    J Neurochem; 2009 Jun 25; 109(5):1469-82. PubMed ID: 19457163
    [Abstract] [Full Text] [Related]

  • 32. Effects of age-related dopaminergic neuron loss in the substantia nigra on the circadian rhythms of locomotor activity in mice.
    Tanaka M, Yamaguchi E, Takahashi M, Hashimura K, Shibata T, Nakamura W, Nakamura TJ.
    Neurosci Res; 2012 Dec 25; 74(3-4):210-5. PubMed ID: 23044185
    [Abstract] [Full Text] [Related]

  • 33. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW.
    Brain Res; 2007 May 30; 1150():55-61. PubMed ID: 17397812
    [Abstract] [Full Text] [Related]

  • 34. A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease.
    Liebetanz D, Baier PC, Paulus W, Meuer K, Bähr M, Weishaupt JH.
    Exp Neurol; 2007 May 30; 205(1):207-13. PubMed ID: 17341420
    [Abstract] [Full Text] [Related]

  • 35. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
    Sagi Y, Mandel S, Amit T, Youdim MB.
    Neurobiol Dis; 2007 Jan 30; 25(1):35-44. PubMed ID: 17055733
    [Abstract] [Full Text] [Related]

  • 36. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 30; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 37. A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in mice.
    Knaryan VH, Samantaray S, Galoyan AA, Mohanakumar KP.
    Neurosci Lett; 2005 Mar 03; 375(3):187-91. PubMed ID: 15694258
    [Abstract] [Full Text] [Related]

  • 38. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 03; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 39. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 03; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 40. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Archer T, Fredriksson A.
    J Neural Transm (Vienna); 2006 Sep 03; 113(9):1119-29. PubMed ID: 16362627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.